Sarepta Therapeutics Inc (SRPT)

NASDAQ HEALTHCARE

$20.30 -0.59% RSI 48 Neutral Add Alert

Moving Averages

SMA 200

$19.47

Price above

Company Profile

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$2.33B

P/E Ratio

None

EPS

$-7.13

Beta

0.283